drugset / Trial / NCT03398876

A Study to Assess the Nicotine Pharmacokinetics, Tolerability and Safety With a New Oral Nicotine Replacement Product in Healthy Japanese Smokers

NCT03398876

Phase 1 Completed 24 enrolled Janssen Pharmaceutical K.K.
RandomizedCrossoverOpen-labelOther

Summary

In Part 1, the purpose of this study is to elucidate the single-dose pharmacokinetic profiles of 1 spray and 2 consecutive sprays of oromucosal nicotine spray (ONS) in comparison with those of nicotine gum and cigarette smoking in healthy Japanese smokers. In Part 2, the purpose is to evaluate the multiple-dose nicotine pharmacokinetics of ONS administered repeated-dose administration in healthy Japanese smokers.

Timeline

Start
2017-12-22
Primary completion
2018-04-16
Completion
2018-04-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown Oral

Indications

No indication recorded.